CRESY on Nasdaq
CRESUD INC
CRESUD INC is a real estate company, listed on Nasdaq (CRESY).1
Price unavailable
Last updated Oct 21, 2026.
Overview
- TickerCRESY on Nasdaq1
- IndustryReal Estate1
- HeadquartersC11
- Incorporated inArgentina3
- Business addressCarlos M. Della Paolera 261, 9Th Floor, Buenos Aires, C1 C1C1001Ada3
- Filer categoryAccelerated filer3
See how the biggest companies compare on our leaderboards
Our legal name is Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria, and our commercial name is “Cresud”. We were incorporated and organized on December 31, 1936, under Argentine law as a stock corporation ( sociedad anónima ) and were registered with the IGJ, on February 19, 1937 under number 26, on page 2, book 45 of National By-laws Volume. Pursuant to our bylaws, our term of duration expires on June 6, 2082.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from. Figures are in ARS, the currency the company reports in.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Operations Center in Argentina brought in 35% of the revenue CRESUD INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operations Center in Argentina | 374.5B ARS | 377.2B ARS | 374.7B ARS |
| Agricultural Production | 388.1B ARS | 374.2B ARS | 327.0B ARS |
| Shopping Malls | 245.7B ARS | 250.5B ARS | 270.5B ARS |
| Hotels | 77.5B ARS | 85.8B ARS | 64.6B ARS |
| Offices | 23.7B ARS | 22.6B ARS | 20.1B ARS |
| Sales and Developments | 22.7B ARS | 12.9B ARS | 12.8B ARS |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue62¢570.7B ARS
- Other costs4¢37.8B ARS
- Interest9¢81.3B ARS
- Profit25¢224.4B ARS
Out of 914.2B ARS in revenue.2
Where each dollar of operating cash went, fiscal 2025
- Capital spending30¢45.7B ARS
- Dividends paid58¢87.4B ARS
- Kept or used elsewhere12¢18.2B ARS
Out of 151.3B ARS of cash from operations.2
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
| Revenues | 914.2B ARS | 959.4B ARS | 986.3B ARS |
| Costs | -570.7B ARS | -571.3B ARS | -597.2B ARS |
| Initial recognition and changes in the fair value of biological assets and agricultural products at the point of harvest | 20.0B ARS | 8.4B ARS | -6.7B ARS |
| Changes in the net realizable value of agricultural products after harvest | 4.6B ARS | 10.0B ARS | -13.1B ARS |
| Gross profit | 368.1B ARS | 406.5B ARS | 369.2B ARS |
| Net gain/ (loss) from fair value adjustment of investment properties | 19.1B ARS | -486.1B ARS | -267.7B ARS |
| Gain from disposal of farmlands | 42.0B ARS | 73.4B ARS | 77.8B ARS |
| General and administrative expenses | -111.0B ARS | -118.3B ARS | -143.9B ARS |
| Selling expenses | -83.1B ARS | -84.2B ARS | -70.2B ARS |
| Other operating results ,net | -5.0B ARS | 29.8B ARS | -46.2B ARS |
| Management fees | -9.1B ARS | -12.9B ARS | -24.8B ARS |
| Profit / (loss) from operations | 220.9B ARS | -191.9B ARS | -105.8B ARS |
| Share of profit of associates and joint ventures | 26.9B ARS | 45.9B ARS | 8.2B ARS |
| Profit / (loss) before financial results and income tax | 247.8B ARS | -146.0B ARS | -97.6B ARS |
| Finance income | 9.4B ARS | 91.1B ARS | 11.4B ARS |
| Finance cost | -81.3B ARS | -102.5B ARS | -122.8B ARS |
| Other financial results | 108.0B ARS | 259.5B ARS | 179.2B ARS |
| Inflation adjustment | 11.4B ARS | -39.5B ARS | 59.6B ARS |
| Financial results, net | 47.6B ARS | 208.6B ARS | 127.4B ARS |
| Profit before income tax | 295.4B ARS | 62.6B ARS | 29.8B ARS |
| Income tax | -71.0B ARS | 86.3B ARS | 376.7B ARS |
| Profit for the year | 224.4B ARS | 148.8B ARS | 406.5B ARS |
| Currency translation adjustment and other comprehensive results from subsidiaries and associates (ii) | -46.8B ARS | -112.6B ARS | 44.2B ARS |
| Revaluation surplus | 332.0M ARS | 5.3B ARS | 2.7B ARS |
| Total other comprehensive (loss)/ income for the year | -46.5B ARS | -107.3B ARS | 46.8B ARS |
| Total comprehensive income for the year | 177.9B ARS | 41.5B ARS | 453.3B ARS |
| Equity holders of the parent | 96.1B ARS | 127.2B ARS | 228.8B ARS |
| Non-controlling interest | 128.2B ARS | 21.6B ARS | 177.7B ARS |
| Equity holders of the parent | 79.3B ARS | 90.5B ARS | 247.9B ARS |
| Non-controlling interest | 98.6B ARS | -49.0B ARS | 205.4B ARS |
| Basic | 160.81 ARS | 214.71 ARS | 380.00 ARS |
| Diluted | 145.22 ARS | 181.25 ARS | 333.96 ARS |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.2
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
| Investment properties | 2.4T ARS | 2.4T ARS | 3.0T ARS |
| Property, plant and equipment | 712.7B ARS | 711.7B ARS | 753.9B ARS |
| Trading properties | 124.7B ARS | 27.2B ARS | 31.3B ARS |
| Intangible assets | 28.5B ARS | 101.1B ARS | 51.6B ARS |
| Group of assets held for sale | 0 ARS | 3.6B ARS | 0 ARS |
| Right of use assets | 122.0B ARS | 111.5B ARS | 97.1B ARS |
| Biological assets | 43.6B ARS | 39.1B ARS | 48.2B ARS |
| Investment in associates and joint ventures | 187.5B ARS | 191.8B ARS | 205.5B ARS |
| Deferred income tax assets | 12.9B ARS | 13.6B ARS | 7.4B ARS |
| Income tax and credit | 76.0M ARS | 19.0M ARS | 114.0M ARS |
| Restricted assets | 0 ARS | 3.8B ARS | 6.2B ARS |
| Trade and other receivables | 175.7B ARS | 197.5B ARS | 174.6B ARS |
| Investment in financial assets | 27.8B ARS | 14.4B ARS | 10.7B ARS |
| Derivative financial instruments | 2.5B ARS | 1.7B ARS | 2.0B ARS |
| Total non-current assets | 3.8T ARS | 3.9T ARS | 4.4T ARS |
| Trading properties | 35.7B ARS | 573.0M ARS | 746.0M ARS |
| Biological assets | 105.7B ARS | 81.3B ARS | 96.8B ARS |
| Inventories | 177.4B ARS | 162.1B ARS | 146.2B ARS |
| Income tax and credit | 1.2B ARS | 3.2B ARS | 5.9B ARS |
| Trade and other receivables | 442.8B ARS | 364.8B ARS | 403.1B ARS |
| Investment in financial assets | 226.2B ARS | 203.7B ARS | 227.0B ARS |
| Derivative financial instruments | 6.8B ARS | 9.4B ARS | 31.9B ARS |
| Cash and cash equivalents | 250.9B ARS | 159.8B ARS | 201.7B ARS |
| Total current assets | 1.2T ARS | 984.9B ARS | 1.1T ARS |
| TOTAL ASSETS | 5.1T ARS | 4.8T ARS | 5.5T ARS |
| Shareholders' equity (according to corresponding statement) | 970.6B ARS | 968.5B ARS | 1.1T ARS |
| Non-controlling interest | 1.2T ARS | 1.2T ARS | 1.4T ARS |
| TOTAL SHAREHOLDERS' EQUITY | 2.2T ARS | 2.2T ARS | 2.5T ARS |
| Trade and other payables | 77.4B ARS | 70.5B ARS | 63.5B ARS |
| Borrowings | 807.4B ARS | 663.1B ARS | 825.4B ARS |
| Deferred income tax liabilities | 863.6B ARS | 889.7B ARS | 1.0T ARS |
| Provisions | 32.4B ARS | 30.1B ARS | 33.5B ARS |
| Payroll and social security liabilities | 124.0M ARS | 1.9B ARS | 1.8B ARS |
| Lease liabilities | 88.4B ARS | 85.4B ARS | 92.4B ARS |
| Derivative financial instruments | 4.0B ARS | 4.3B ARS | 240.0M ARS |
| Total non-current liabilities | 1.9T ARS | 1.7T ARS | 2.0T ARS |
| Trade and other payables | 330.5B ARS | 348.6B ARS | 393.5B ARS |
| Borrowings | 535.8B ARS | 483.7B ARS | 532.0B ARS |
| Provisions | 5.2B ARS | 6.4B ARS | 4.5B ARS |
| Payroll and social security liabilities | 38.1B ARS | 28.1B ARS | 35.2B ARS |
| Income tax liabilities | 56.7B ARS | 9.3B ARS | 8.6B ARS |
| Lease liabilities | 31.9B ARS | 25.8B ARS | 30.2B ARS |
| Derivative financial instruments | 3.6B ARS | 16.9B ARS | 6.5B ARS |
| Total Current liabilities | 1.0T ARS | 919.0B ARS | 1.0T ARS |
| TOTAL LIABILITIES | 2.9T ARS | 2.7T ARS | 3.0T ARS |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 5.1T ARS | 4.8T ARS | 5.5T ARS |
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
| Investment properties | 2.4T ARS | 2.4T ARS | 3.0T ARS |
| Property, plant and equipment | 712.7B ARS | 711.7B ARS | 753.9B ARS |
| Trading properties | 124.7B ARS | 27.2B ARS | 31.3B ARS |
| Intangible assets | 28.5B ARS | 101.1B ARS | 51.6B ARS |
| Group of assets held for sale | 0 ARS | 3.6B ARS | 0 ARS |
| Right of use assets | 122.0B ARS | 111.5B ARS | 97.1B ARS |
| Biological assets | 43.6B ARS | 39.1B ARS | 48.2B ARS |
| Investment in associates and joint ventures | 187.5B ARS | 191.8B ARS | 205.5B ARS |
| Deferred income tax assets | 12.9B ARS | 13.6B ARS | 7.4B ARS |
| Income tax and credit | 76.0M ARS | 19.0M ARS | 114.0M ARS |
| Restricted assets | 0 ARS | 3.8B ARS | 6.2B ARS |
| Trade and other receivables | 175.7B ARS | 197.5B ARS | 174.6B ARS |
| Investment in financial assets | 27.8B ARS | 14.4B ARS | 10.7B ARS |
| Derivative financial instruments | 2.5B ARS | 1.7B ARS | 2.0B ARS |
| Total non-current assets | 3.8T ARS | 3.9T ARS | 4.4T ARS |
| Trading properties | 35.7B ARS | 573.0M ARS | 746.0M ARS |
| Biological assets | 105.7B ARS | 81.3B ARS | 96.8B ARS |
| Inventories | 177.4B ARS | 162.1B ARS | 146.2B ARS |
| Income tax and credit | 1.2B ARS | 3.2B ARS | 5.9B ARS |
| Trade and other receivables | 442.8B ARS | 364.8B ARS | 403.1B ARS |
| Investment in financial assets | 226.2B ARS | 203.7B ARS | 227.0B ARS |
| Derivative financial instruments | 6.8B ARS | 9.4B ARS | 31.9B ARS |
| Cash and cash equivalents | 250.9B ARS | 159.8B ARS | 201.7B ARS |
| Total current assets | 1.2T ARS | 984.9B ARS | 1.1T ARS |
| TOTAL ASSETS | 5.1T ARS | 4.8T ARS | 5.5T ARS |
| Shareholders' equity (according to corresponding statement) | 970.6B ARS | 968.5B ARS | 1.1T ARS |
| Non-controlling interest | 1.2T ARS | 1.2T ARS | 1.4T ARS |
| TOTAL SHAREHOLDERS' EQUITY | 2.2T ARS | 2.2T ARS | 2.5T ARS |
| Trade and other payables | 77.4B ARS | 70.5B ARS | 63.5B ARS |
| Borrowings | 807.4B ARS | 663.1B ARS | 825.4B ARS |
| Deferred income tax liabilities | 863.6B ARS | 889.7B ARS | 1.0T ARS |
| Provisions | 32.4B ARS | 30.1B ARS | 33.5B ARS |
| Payroll and social security liabilities | 124.0M ARS | 1.9B ARS | 1.8B ARS |
| Lease liabilities | 88.4B ARS | 85.4B ARS | 92.4B ARS |
| Derivative financial instruments | 4.0B ARS | 4.3B ARS | 240.0M ARS |
| Total non-current liabilities | 1.9T ARS | 1.7T ARS | 2.0T ARS |
| Trade and other payables | 330.5B ARS | 348.6B ARS | 393.5B ARS |
| Borrowings | 535.8B ARS | 483.7B ARS | 532.0B ARS |
| Provisions | 5.2B ARS | 6.4B ARS | 4.5B ARS |
| Payroll and social security liabilities | 38.1B ARS | 28.1B ARS | 35.2B ARS |
| Income tax liabilities | 56.7B ARS | 9.3B ARS | 8.6B ARS |
| Lease liabilities | 31.9B ARS | 25.8B ARS | 30.2B ARS |
| Derivative financial instruments | 3.6B ARS | 16.9B ARS | 6.5B ARS |
| Total Current liabilities | 1.0T ARS | 919.0B ARS | 1.0T ARS |
| TOTAL LIABILITIES | 2.9T ARS | 2.7T ARS | 3.0T ARS |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 5.1T ARS | 4.8T ARS | 5.5T ARS |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|
| Net cash generated from operating activities before income tax paid | 159.7B ARS | 127.3B ARS | 218.0B ARS |
| Income tax paid | -8.4B ARS | -11.8B ARS | -30.0B ARS |
| Net cash generated from operating activities | 151.3B ARS | 115.4B ARS | 188.0B ARS |
| Proceeds from the sale of participation in associates and joint ventures | 6.5B ARS | 33.2B ARS | 0 ARS |
| Capital contributions to associates and joint ventures | -35.0M ARS | 0 ARS | -123.0M ARS |
| Contributions to associates and joint ventures pending subscription | 0 ARS | 0 ARS | -234.0M ARS |
| Acquisition and improvement of investment properties | -39.3B ARS | -17.9B ARS | -30.6B ARS |
| Proceeds from sales of investment properties | 7.8B ARS | 49.9B ARS | 117.3B ARS |
| Acquisitions and improvements of property, plant and equipment | -45.7B ARS | -109.3B ARS | -94.3B ARS |
| Acquisition of intangible assets | -2.8B ARS | -3.0B ARS | -1.9B ARS |
| Proceeds from sales of property, plant and equipment | 27.9B ARS | 108.8B ARS | 92.4B ARS |
| Dividends collected from associates and joint ventures | 3.8B ARS | 17.3B ARS | 3.3B ARS |
| Proceeds from loans granted | 1.2B ARS | 2.3B ARS | 2.8B ARS |
| Acquisitions of investments in financial assets | -757.8B ARS | -771.9B ARS | -287.1B ARS |
| Proceeds from disposal of investments in financial assets | 690.1B ARS | 789.1B ARS | 270.7B ARS |
| Interest received from financial assets | 28.1B ARS | 27.2B ARS | 620.0M ARS |
| Payments of derivative financial instruments, net | -318.0M ARS | 3.3B ARS | 4.3B ARS |
| Net cash (used in) / generated from investing activities | -80.6B ARS | 129.1B ARS | 77.3B ARS |
| Borrowings, issuance and new placement of non-convertible notes | 698.0B ARS | 423.7B ARS | 543.6B ARS |
| Payment of borrowings and non-convertible notes | -338.7B ARS | -401.2B ARS | -570.9B ARS |
| (Payment) / obtaining of short term loans, net | -11.2B ARS | 45.4B ARS | 21.7B ARS |
| Interest paid | -89.3B ARS | -176.0B ARS | -177.5B ARS |
| Capital contributions from non-controlling interest in subsidiaries | 235.0M ARS | 134.0M ARS | 10.0M ARS |
| Lease liabilities paid | -5.0B ARS | -3.8B ARS | -1.9B ARS |
| Repurchase of treasury shares | -16.5B ARS | -18.4B ARS | -35.6B ARS |
| Dividends paid | -87.4B ARS | -172.3B ARS | -227.2B ARS |
| Exercise of warrants | 11.8B ARS | 3.1B ARS | 1.0B ARS |
| Repurchase of non-convertible notes | -75.7B ARS | -11.1B ARS | -24.8B ARS |
| Net cash generated from / (used in) financing activities | 86.2B ARS | -310.5B ARS | -471.7B ARS |
| Net increase / (decrease) in cash and cash equivalents | 156.9B ARS | -66.0B ARS | -206.4B ARS |
| Foreign exchange gain on cash and unrealized fair value result for cash equivalents | 28.5B ARS | 51.2B ARS | 37.1B ARS |
| Inflation adjustment | -94.4B ARS | -27.0B ARS | -18.8B ARS |
No quarter-by-quarter statement was filed.
Corporate structure
CRESUD INC sits at the top of its group. 2 entities on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of CRESUD INC
- Kopernik Global Investors, LLC Filed SCHEDULE 13G on CRESUD INC, latest Jun 18, 2026
- Eduardo S. Elsztain Filed SC 13D/A on CRESUD INC, latest Jul 13, 2023
- CRESUD INC C1
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.
What it owns
What CRESUD INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, net | 712.7B ARS2 Jun 30, 2025 | 711.7B ARS2 Jun 30, 2024 | +0.1% |
| Operating-lease assets (leased space) | 122.0B ARS2 Jun 30, 2025 | 111.5B ARS2 Jun 30, 2024 | +9.4% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | 250.9B ARS2 Jun 30, 2025 | 159.8B ARS2 Jun 30, 2024 | +57.0% |
| Long-term investments | 27.8B ARS2 Jun 30, 2025 | 14.4B ARS2 Jun 30, 2024 | +93.7% |
Intangibles and goodwill
Inventory
Leadership
Who has led CRESUD INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
- Chief executive officerAlejandro Gustavo Elsztain Sep 22, 2026 to now11
Board members and other officers (11)
- General Mgr. Op. in ArgentinaBiaus Diego Chillado Mar 18, 2026 to now12
- Board memberAlejandro Gustavo Casaretto Mar 18, 2026 to now13
- Board memberAlejandro Gustavo Elsztain Mar 18, 2026 to now14
- Board memberAlejandro Mario Bartolome Mar 18, 2026 to now15
- Board memberEnrique Alberto Antonini Mar 18, 2026 to now16
- Board memberFernando Adrian Elsztain Mar 18, 2026 to now17
- Board memberLiliana Irene Glikin Mar 18, 2026 to now18
- Board memberMariana Renata Carmona Mar 18, 2026 to now19
- Board memberNicolas Bendersky Mar 18, 2026 to now20
- Board memberSaul Zang Mar 18, 2026 to now21
- Board memberMaria Gabriela Macagni Mar 19, 2026 to now22
Timeline
- Sep 22, 2026New chief executive Alejandro Gustavo Elsztain becomes CEO11
Calendar
Coming up
- Nov 9, 2026Reports results for the quarter ending Sep/202623
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
374 filings to the SEC since October 2021: 7 annual reports, 27 insider forms, 2 large holders, 338 other. The latest 20:
- Oct 15, 20264 EDGAR
- Oct 1, 20264 EDGAR
- Sep 22, 20264 EDGAR
- Sep 17, 20266-K SHAREHOLDERS' MEETING ANNOUNCEMENT EDGAR
- Sep 14, 20264 EDGAR
- Sep 8, 20266-K ART. 62 EDGAR
- Sep 4, 20266-K INSTALLMENT CLASS L EDGAR
- Aug 28, 20266-K MATERIAL FACT EDGAR
- Aug 27, 20266-K NOTES ISSUANCE EDGAR
- Aug 27, 20266-K INSTALLMENT CLASS XLIX EDGAR
- Aug 26, 20264 EDGAR
- Aug 21, 20264 PRIMARY DOCUMENT EDGAR
- Aug 14, 20266-K INSTALLMENT & CAPITAL PAYMENT CLASS XLV EDGAR
- Aug 13, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 14, 20266-K INSTALLMENT CLASS LI EDGAR
- Jul 14, 20266-K INSTALLMENT CLASS XLVI EDGAR
- Jul 8, 20266-K SERIES XLIV NOTES REDEMPTION EDGAR
- Jul 2, 20266-K INSTALLMENT CLASS XLVIII EDGAR
The 374 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
16 open-market trades by officers, directors and large owners since October 2021: 6 buys and 10 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Elsztain Fernando AdrianDirector | Sale | 65,000 | $1.25 | $81.2K | Form 4 |
| Sep 9, 2026 | Elsztain Fernando AdrianDirector | Sale | 35,000 | $1.19 | $41.6K | Form 4 |
| Aug 24, 2026 | Elsztain Fernando AdrianDirector | Sale | 10,000 | $1.05 | $10.5K | Form 4 |
| Aug 20, 2026 | Elsztain Fernando AdrianDirector | Sale | 10,000 | $1.10 | $11.0K | Form 4 |
| Aug 12, 2026 | Elsztain Fernando AdrianDirector | Sale | 10,000 | $1.06 | $10.6K | Form 4 |
| Jul 22, 2026 | Elsztain Fernando AdrianDirector | Sale | 20,000 | $1.17 | $23.4K | Form 4 |
| Jul 21, 2026 | Elsztain Fernando AdrianDirector | Sale | 15,000 | $1.13 | $16.9K | Form 4 |
| Jul 6, 2026 | Elsztain Fernando AdrianDirector | Sale | 4,385 | $1.11 | $4.9K | Form 4 |
| Jun 11, 2026 | Elsztain Fernando AdrianDirector | Sale | 70,000 | $1.26 | $88.2K | Form 4 |
| Jun 5, 2026 | Elsztain Alejandro GustavoCEO | Buy | 18,200 | $10.95 | $199.3K | Form 4 |
| May 20, 2026 | Zang SaulDirector | Buy | 17,000 | $10.63 | $180.7K | Form 4 |
| May 14, 2026 | ELSZTAIN EDUARDO SDirector | Buy | 8,823 | $10.67 | $94.1K | Form 4 |
| May 13, 2026 | ELSZTAIN EDUARDO SDirector | Buy | 58,595 | $10.57 | $619.3K | Form 4 |
| Apr 23, 2026 | Elsztain Alejandro GustavoCEO | Buy | 4,458 | $11.20 | $49.9K | Form 4 |
| Apr 22, 2026 | Elsztain Alejandro GustavoCEO | Buy | 13,375 | $11.23 | $150.2K | Form 4 |
| Apr 21, 2026 | Elsztain Fernando AdrianDirector | Sale | 31,000 | $1.16 | $36.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Kopernik Global Investors, LLCSCHEDULE 13G, 1 filing Jun 18, 202624
- Eduardo S. ElsztainSC 13D/A, 1 filing Jul 13, 202325
Stakes it holds
CRESUD INC has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).
- BrasilAgro - Brazilian Agricultural Real Estate CoSC 13G/A Feb 11, 2022 to Sep 19, 202326
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 57. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How CRESUD INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCRESUD INC1
- CIK0001034957
- Filer statusAccelerated filer not an emerging growth company; not a shell company4
- Incorporated inArgentina4
- Fiscal year endsJune 301
- Industry code (SIC)6500 Real Estate1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business addressCarlos M. Della Paolera 261, 9Th Floor, Buenos Aires, C1 C1C1001ADA1
- Phone005411432374491
- Shares outstanding614,074,273 shares as of Oct 14, 20254
- AuditorPRICE WATERHOUSE & Co. S.R.L., Buenos Aires, Argentina PCAOB ID 1349; it also attests to the company’s internal control over financial reporting4
- On EDGAR sinceApr 3, 19971
- Filings1,852 in all: 6-K (1,560), 4 (64), SC 13D/A (39), 20-F (25), UPLOAD (25), CORRESP (21), SC 13G/A (21), 3 (14)1
All 29 form types
6-K/A (13), 20-F/A (10), F-3/A (9), 144 (8), SC 13D (8), SC 13G (6), 424B1 (4), 3/A (3), F-3 (3), 25-NSE (2), 4/A (2), 8-A12B (2), EFFECT (2), F-6EF (2), NT 20-F (2), POS462C (2), AW (1), CERT (1), CERTNAS (1), POS AM (1), SCHEDULE 13G (1)
- Latest filingsAnnual report (20-F) Oct 24, 2025
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value ARS 1.00 per share | CRESY | Nasdaq |
From the cover page of the 20-F filed Oct 24, 2025 (Section 12(b) of the Exchange Act).4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCRESUD INC filings on SEC EDGAR
- 2SEC EDGARCRESUD INC 10-K for fiscal 2025
- 3SEC EDGARCRESUD INC filings on SEC EDGAR
- 4
- 5SEC EDGARCRESUD INC 10-K for fiscal 2018
- 6SEC EDGARCRESUD INC 10-K for fiscal 2019
- 7SEC EDGARCRESUD INC 10-K for fiscal 2020
- 8SEC EDGARCRESUD INC 10-K for fiscal 2021
- 9SEC EDGARCRESUD INC 10-K for fiscal 2022
- 10SEC EDGARCRESUD INC 10-K for fiscal 2018
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARLiliana Irene Glikin, Board member
- 19SEC EDGARMariana Renata Carmona, Board member
- 20SEC EDGARNicolas Bendersky, Board member
- 21SEC EDGARSaul Zang, Board member
- 22SEC EDGARMaria Gabriela Macagni, Board member
- 23NasdaqNasdaq calendar
- 24
- 25
- 26